Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

4.30USD
12:06am IST
Change (% chg)

$-0.09 (-2.05%)
Prev Close
$4.39
Open
$4.44
Day's High
$4.48
Day's Low
$4.28
Volume
17,689
Avg. Vol
61,316
52-wk High
$5.67
52-wk Low
$2.40

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $170.63
Shares Outstanding(Mil.): 41.42
Dividend: --
Yield (%): --

Financials

BRIEF-Fate Therapeutics announces issuance of U.S. patent covering use of viral transduction enhancers in gene therapy

* Fate Therapeutics announces issuance of U.S. patent covering use of viral transduction enhancers in gene therapy

16 Aug 2017

BRIEF-Fate Therapeutics Q2 ‍net loss per common share $0.23​

* Fate Therapeutics reports second quarter 2017 financial results

15 Aug 2017

BRIEF-Fate Therapeutics to amend and restate loan and security agreement

* Fate Therapeutics Inc - on July 14, 2017 co entered into first amendment to amended and restated loan and security agreement - SEC filing

15 Jul 2017

Earnings vs. Estimates